-
公开(公告)号：US07592372B2
公开(公告)日：2009-09-22
申请号：US10477758
申请日：2002-05-24
IPC分类号： A61K31/195 , A61K31/198 , A61K9/08
CPC分类号： A61K9/0095 , A61K31/198 , A61K39/35 , A61K45/06 , A61K47/02 , A61K47/12 , A61K47/26 , A61K2300/00
摘要： Liquid drug preparations characterized by containing fudostein and an acid together with a sweetener such as sugar alcohol, trehalose or a sweetener having a high degree of sweetness. These liquid drug preparations are fudostein-containing liquid drug preparations which are free from color change or sedimentation upon prolonged storage and can be easily taken.
摘要翻译： 液体药物制剂的特征在于含有福杜斯汀和酸与甜味剂如糖醇，海藻糖或具有高度甜度的甜味剂一起含有。 这些液体药物制剂是富含纤维蛋白的液体药物制剂，其在长期储存时没有变色或沉淀，并且可以容易地服用。
-
公开(公告)号：US5225206A
公开(公告)日：1993-07-06
申请号：US830919
申请日：1992-02-04
IPC分类号： A61K9/16 , A61K9/20 , A61K9/22 , A61K9/28 , A61K9/50 , A61K9/52 , A61K31/435 , A61K31/44 , A61K47/12 , A61K47/32 , A61K47/38 , A61K47/44 , A61P29/00
CPC分类号： A61K31/44 , A61K9/2077 , A61K9/2081 , A61K9/5015 , A61K9/5026 , A61K9/5042 , A61K9/5047 , A61K9/5073 , A61K9/5078 , Y10S514/963
摘要： A sustained-release pranoprofen preparation is disclosed. The preparation comprises an effective amount of pranoprofen and one or more sustained-release components selected from the group consisting of oily components, water-soluble components, water-insoluble components, and intestinally soluble components. It controls release of pranoprofen and lowers the maximum pranoprofen concentration in blood, maintaining its concentration in blood at a certain level for a long period of time. It reduces risks of side effects and can effectively treat diseases with dosing once or twice a day.
-
搜索结果
2 条记录 (耗时 0.009 秒)
